Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
How Early Data Drives Better Cell Line Performance
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest phases of cell line development. read more
AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Valion Bio Highlights Scale-Up And Oncology Plans For Entolimod Biodefense Platform
Tuesday, July 14, 2026
Valion Bio reported a set of strategic developments around its Toll like receptor 5 (TLR5) agonist Entolimod, underscoring plans to build an ... read more
Formycon And OneSource Sign Biosimilars Manufacturing Partnership
Tuesday, July 14, 2026
Formycon AG and OneSource Specialty Pharma have entered a strategic manufacturing partnership to support Formycon’s biosimilar programs for global ... read more
Charles River Provides NGS Services to Arovella Therapeutics
Tuesday, July 14, 2026
Charles River Laboratories International announced a collaboration with Arovella Therapeutics, a biotechnology company, to provide Good Manufacturing ... read more
Kindeva Appoints Chief Transformation Officer
Monday, July 13, 2026
Kindeva announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and ... read more
Axplora Manufacturing Sites Earn EcoVadis Ratings Across European Network
Thursday, July 09, 2026
Axplora reported updated EcoVadis sustainability ratings for four of its European manufacturing sites, with one site achieving platinum status and ... read more